WSU study suggests returning students didn’t drive COVID-19 outbreaks in town
Peer-Reviewed Publication
Updates every hour. Last Updated: 27-Aug-2025 14:11 ET (27-Aug-2025 18:11 GMT/UTC)
Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their highly effective vaccines to fight the virus.
Since then, scientists have been fine-tuning this vaccine delivery system to make it more effective. A Yale research team has now developed a technology that improves both the power of mRNA vaccines and their effectiveness against a host of diseases.
The new technology offers the promise of expanding the reach of these vaccines, including for the prevention of other diseases, including cancer and autoimmune diseases.
The results of their study are published in Nature Biomedical Engineering.
The American College of Cardiology has issued Concise Clinical Guidance (CCG) recommending vaccines to protect adults with heart disease against respiratory illness, including influenza, COVID-19 and RSV, and other diseases where vaccination is shown to offer cardiovascular protective benefits. The guidance also provides detailed evidence for each vaccine recommendation and answers to frequently asked questions to guide conversations between clinicians and patients.
A new global study has identified striking inequalities in disability caused by COVID-19 during 2020–2021, offering an early warning signal for the ongoing risk of long COVID in the years that followed — and even today. By examining across 920 locations worldwide, researchers found that low- and middle-income countries (LMICs), especially in Sub-Saharan Africa, showed disproportionately high rates of nonfatal COVID-related health loss. These findings highlight potentially hidden vulnerabilities and call for urgent action to address long-term pandemic effects in underserved populations.
A mindset intervention helped people reflect on the COVID-19 pandemic to see that the experience held some growth opportunities. Later, those who had made this shift in their views showed positive signs not only in self-reported mental health, but also in their blood.
The COVID-19 pandemic highlighted how the same health information affects the behavior of individuals differently. A recent study revealed cultural differences in how people respond to hypothetical COVID-19 infection information at the local level. The analysis also found differences in how individual subgroups react differently to pandemic information.
The COVID-19 pandemic highlighted how the same health information affects the behavior of individuals differently. A recent study revealed cultural differences in how people respond to hypothetical COVID-19 infection information at the local level. The analysis also found differences in how individual subgroups react differently to pandemic information.
A new national study led by researchers from Carleton University and the University of Toronto reveals that older adults living in greener neighborhoods were less likely to experience depression during the early months of the COVID-19 pandemic.
When SARS-CoV-2, the coronavirus that causes COVID-19, began spreading worldwide in 2020, many research teams immediately set to work developing a vaccine against it. Building on decades of previous work on mRNA technology and on other viral vaccines, including HIV, they achieved their goal within the year. The most widely used mRNA vaccine design contains the genetic instructions for the body to make the spike protein that the virus uses to enter cells. The resulting immune response protects against infection and, more importantly, disease and death. However, developing a vaccine for HIV has proven much more difficult.